Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DX25F6VBR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,541
Award facts
- Contract value 100% obligated
- $11,540.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cosentyx (secukinumab) Unoready 300 mg pen auto-injectors in 2 ml formulation. This competitive award, valued at $11,540.62 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate completion date of September 17, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this procurement as part of its comprehensive role supplying medications and medical commodities to military and veteran healthcare systems. The broader SPE2DX contract vehicle enables the company to deliver a wide range of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis. Cosentyx is a biologic immunosuppressant used primarily for autoimmune conditions, reflecting the specialized pharmaceutical capabilities AmerisourceBergen provides through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DX25F6VBR?
SPE2DX25F6VBR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25F6VBR worth?
The government has obligated $11,541 on SPE2DX25F6VBR.
Is contract SPE2DX25F6VBR an order under another contract?
Yes. SPE2DX25F6VBR is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6VBR competed?
The extent of competition for SPE2DX25F6VBR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award